Belite Bio, Inc (BLTE) Misses Q2 EPS by 3c
Belite Bio, Inc (NASDAQ: BLTE) reported Q2 EPS of ($0.26), $0.03 worse than the analyst estimate of ($0.23).
For earnings history and earnings-related data on Belite Bio, Inc (BLTE) click here.
Belite Bio, Inc (NASDAQ: BLTE) reported Q2 EPS of ($0.26), $0.03 worse than the analyst estimate of ($0.23).
For earnings history and earnings-related data on Belite Bio, Inc (BLTE) click here.